{
    "code": "52026987",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026987",
    "time": "2023-12-28 21:45:05",
    "許可證字號": "衛部藥輸字第026987號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/02\/14",
    "發證\/登錄日期": "106\/02\/14",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202698701",
    "中文品名": "安立復美達持續性藥效肌肉注射用懸浮劑400毫克\/預充填注射筒",
    "英文品名": "ABILIFY MAINTENA (aripiprazole) for extended-release injectable suspension, 400mg\/Pre-filled dual chamber syringe",
    "適應症": "治療成人的思覺失調症。成人的第一型雙極性疾患維持治療之單一療法。",
    "劑型": "243凍晶注射劑",
    "包裝": "一支預充填注射針筒(含Aripiprazole凍晶粉末及滅菌注射用水)及3支安全針頭預充填注射針筒裝附3支安全針頭",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "111\/02\/14",
    "主成分略述": "Aripiprazole Monohydrate",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "台灣大塚製藥股份有限公司",
    "申請商地址": "台北市中山區復興北路378號11樓",
    "主製造廠": [
        {
            "製造廠名稱": "OTSUKA PHARMACEUTICAL CO., LTD. TOKUSHIMA WAJIKI FACOTRY",
            "製造廠廠址": "306-2 AZA OTSUBO,KONIU,NAKA-CHO NAKA-GUN,TOKUSHIMA 771-5209 JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "臺灣大塚製藥股份有限公司中壢工廠",
            "製造廠廠址": "桃園市中壢區吉林路15號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "貼標廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200095420",
            "成分名稱": "Aripiprazole Monohydrate",
            "含量描述": "Aripiprazole Monohydrate (equivalent to aripiprazole anhydrous 400mg\/syringe)",
            "含量": "400.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "安立復美達_肌肉注射用印妥仿單-111-04-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026987&Seq=005&Type=9"
        },
        {
            "title": "Abilify Maintena DCS 400mg_QRG_deltoid addition_final-107-01-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026987&Seq=006&Type=8"
        },
        {
            "title": "Abilify Maintena DCS 400mg_label for syringe_deltoid addition_final-107-01-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026987&Seq=005&Type=8"
        },
        {
            "title": "Abilify Maintena DCS 400mg_carton_deltoid addition_final-107-01-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026987&Seq=004&Type=8"
        }
    ]
}